Latest raise
$90M
Date raised
November 5, 2026
Round
Series A
InvestorsSofinnova Partners, RA Capital Management
Websitealethiotherapeutics.com
About Beth Psaila
a biopharmaceutical company developing therapies for myeloproliferative neoplasms (MPNs)
- Who is Beth Psaila?
- Beth Psaila is listed as Co-founder of Alethio Therapeutics based in Oxford, United Kingdom.
- How much did Alethio Therapeutics raise?
- Alethio Therapeutics raised $90M in a Series A round on November 5, 2026. Backed by Sofinnova Partners, RA Capital Management.
Get newly funded founders every week
A free weekly list of startups that just raised.